SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (725)2/18/2002 9:36:19 PM
From: scaram(o)uche  Read Replies (2) of 1833
 
for all the wrong reasons, KDUS makes BioCentury this week......

‘Tennis anyone?’
Although Icahn did not make himself available for interviews
last week, the financier has been a fellow traveler with
IMCL management in the past. He was
involved in Cadus Pharmaceutical Corp.
(KDUS, Tarrytown, N.Y.), which was
founded in 1992 by IMCL and scientists
from Princeton University and the University
of North Carolina at Chapel Hill
to develop therapeutics for inflammation,
cardiovascular and CNS disorders.
To help keep itself afloat, IMCL
sold its remaining 50% interest in Cadus
to a Carl Icahn affiliate for $3 million in
January 1995.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News